<?xml version="1.0"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
<channel>
<title>BloggingStocks</title>
<link>http://www.bloggingstocks.com</link>
<description>BloggingStocks</description>
<image>
<url>http://www.blogsmithmedia.com/http://www.bloggingstocks.com/media/feedlogo.gif</url>
<title>BloggingStocks</title>
<link>http://www.bloggingstocks.com</link>
</image>
<language>en-us</language>
<copyright>Copyright 2012 Weblogs, Inc. The contents of this feed are available for non-commercial use only.</copyright>
<generator>Blogsmith http://www.blogsmith.com/</generator><item><title><![CDATA[InterMune Showered with Analyst Love on FDA Approval]]></title><link>http://www.bloggingstocks.com/2010/03/10/intermune-showered-with-analyst-love-on-fda-approval/</link><guid isPermaLink="true">http://www.bloggingstocks.com/2010/03/10/intermune-showered-with-analyst-love-on-fda-approval/</guid><comments>http://www.bloggingstocks.com/2010/03/10/intermune-showered-with-analyst-love-on-fda-approval/#comments</comments><description><![CDATA[<p>Filed under: <a href="http://www.bloggingstocks.com/category/major-movement/" rel="tag">Major Movement</a>, <a href="http://www.bloggingstocks.com/category/analyst-reports/" rel="tag">Analyst Reports</a>, <a href="http://www.bloggingstocks.com/category/analyst-upgrades-and-downgrades/" rel="tag">Analyst Upgrades and Downgrades</a>, <a href="http://www.bloggingstocks.com/category/good-news/" rel="tag">Good news</a>, <a href="http://www.bloggingstocks.com/category/products-and-services/" rel="tag">Products and Services</a></p><p><img hspace="4" vspace="4" border="1" align="right" alt=""  src="http://www.blogcdn.com/www.bloggingstocks.com/media/2010/03/intermune-logo.jpg" />Late Tuesday, an advisory panel of the Food &amp; Drug Administration (FDA) <a href="http://www.dddmag.com/news-Panel-Votes-In-Favor-of-InterMune-Drug-31010.aspx">voiced its approval</a> for pirfenidone, the experimental lung drug from InterMune (<a href="http://www.dailyfinance.com/quotes/intermune-inc/itmn/nas">ITMN</a>). The panel voted 9-3 in favor of recommending pirfenidone to patients with idiopathic pulmonary fibrosis.</p>
<p>The FDA is expected to follow the advice of the advisory panel, although it's not required to do so. The regulatory agency is due to issue its final ruling on the drug's fate by early May.</p><p><a href="http://www.bloggingstocks.com/2010/03/10/intermune-showered-with-analyst-love-on-fda-approval/" rel="bookmark">Continue reading <em>InterMune Showered with Analyst Love on FDA Approval</em></a></p><p style="padding:5px;background:#ddd;border:1px solid #ccc;clear:both;"><a href="http://www.bloggingstocks.com/2010/03/10/intermune-showered-with-analyst-love-on-fda-approval/">InterMune Showered with Analyst Love on FDA Approval</a> originally appeared on <a href="http://www.bloggingstocks.com">BloggingStocks</a> on Wed, 10 Mar 2010 12:00:00 EST.  Please see our <a href="http://www.weblogsinc.com/feed-terms/">terms for use of feeds</a>.</p><h6 style="clear: both; padding: 8px 0 0 0; height: 2px; font-size: 1px; border: 0; margin: 0; padding: 0;"></h6><a href="http://www.bloggingstocks.com/2010/03/10/intermune-showered-with-analyst-love-on-fda-approval/" rel="bookmark" title="Permanent link to this entry">Permalink</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/forward/19391445/" title="Send this entry to a friend via email">Email this</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/2010/03/10/intermune-showered-with-analyst-love-on-fda-approval/#comments" title="View reader comments on this entry">Comments</a>]]></description><category>analyst upgrades</category><category>Baird</category><category>FDA</category><category>InterMune</category><category>ITMN</category><category>pirfenidone</category><category>price target</category><category>short interest</category><dc:creator><![CDATA[Elizabeth Harrow]]></dc:creator><pubDate>Wed, 10 Mar 2010 12:00:00 EST</pubDate></item><item><title><![CDATA[Starbucks second quarter earnings preview]]></title><link>http://www.bloggingstocks.com/2009/04/28/starbucks-second-quarter-earnings-preview/</link><guid isPermaLink="true">http://www.bloggingstocks.com/2009/04/28/starbucks-second-quarter-earnings-preview/</guid><comments>http://www.bloggingstocks.com/2009/04/28/starbucks-second-quarter-earnings-preview/#comments</comments><description><![CDATA[<p>Filed under: <a href="http://www.bloggingstocks.com/category/earnings-reports/" rel="tag">Earnings Reports</a>, <a href="http://www.bloggingstocks.com/category/forecasts/" rel="tag">Forecasts</a>, <a href="http://www.bloggingstocks.com/category/products-and-services/" rel="tag">Products and Services</a>, <a href="http://www.bloggingstocks.com/category/consumer-experience/" rel="tag">Consumer Experience</a>, <a href="http://www.bloggingstocks.com/category/competitive-strategy/" rel="tag">Competitive Strategy</a>, <a href="http://www.bloggingstocks.com/category/sbux/" rel="tag">Starbucks (SBUX)</a>, <a href="http://www.bloggingstocks.com/category/recession/" rel="tag">Recession</a></p><img hspace="4" border="0" align="right" vspace="4" alt="Starbucks Earnings Preview" src="http://www.blogcdn.com/www.bloggingstocks.com/media/2009/01/sbux_coffee__cup_240.jpg" />Earnings season continues to move right along, and Wednesday following the market close coffee giant <a href="http://finance.aol.com/quotes/starbucks-corporation/sbux/nas">Starbucks Corporation</a> (NASDAQ: <a href="http://finance.aol.com/quotes/starbucks-corporation/sbux/nas">SBUX</a>) will get its chance to impress Wall Street.<br /><br />The last time that the company reported earnings was back on January 28 when it failed to meet analyst expectations by posting 15 cents per share versus analyst estimates for 17 cents a share. This time around, analysts are looking for the company to show 15 cents a share for its fiscal second quarter.<p><a href="http://www.bloggingstocks.com/2009/04/28/starbucks-second-quarter-earnings-preview/" rel="bookmark">Continue reading <em>Starbucks second quarter earnings preview</em></a></p><p style="padding:5px;background:#ddd;border:1px solid #ccc;clear:both;"><a href="http://www.bloggingstocks.com/2009/04/28/starbucks-second-quarter-earnings-preview/">Starbucks second quarter earnings preview</a> originally appeared on <a href="http://www.bloggingstocks.com">BloggingStocks</a> on Tue, 28 Apr 2009 17:40:00 EST.  Please see our <a href="http://www.weblogsinc.com/feed-terms/">terms for use of feeds</a>.</p><h6 style="clear: both; padding: 8px 0 0 0; height: 2px; font-size: 1px; border: 0; margin: 0; padding: 0;"></h6><a href="http://www.bloggingstocks.com/2009/04/28/starbucks-second-quarter-earnings-preview/" rel="bookmark" title="Permanent link to this entry">Permalink</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/forward/1530838/" title="Send this entry to a friend via email">Email this</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/2009/04/28/starbucks-second-quarter-earnings-preview/#comments" title="View reader comments on this entry">Comments</a>]]></description><category>Baird</category><category>coffee</category><category>earnings</category><category>earnings preview</category><category>EarningsPreview</category><category>luxury items</category><category>LuxuryItems</category><category>SBUX</category><category>Starbucks</category><dc:creator><![CDATA[Michael Fowlkes]]></dc:creator><pubDate>Tue, 28 Apr 2009 17:40:00 EST</pubDate></item></channel></rss>
